Marshall Wace North America’s Stoneridge SRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-19,730
Closed -$622K 1532
2019
Q2
$622K Buy
+19,730
New +$584K ﹤0.01% 849
2018
Q3
Sell
-29,269
Closed -$1.03M 1341
2018
Q2
$1.03M Buy
29,269
+4,919
+20% +$149K 0.01% 921
2018
Q1
$672K Buy
+24,350
New +$595K ﹤0.01% 1092
2017
Q4
Sell
-124,155
Closed -$2.48M 1596
2017
Q3
$2.48M Buy
124,155
+66,632
+116% +$1.1M 0.02% 744
2017
Q2
$863K Buy
57,523
+14,606
+34% +$245K 0.01% 974
2017
Q1
$773K Buy
+42,917
New +$755K 0.01% 741

Other funds holding SRI

Marshall Wace North America's SRI Position: Q3 2019 in Review

Marshall Wace North America sold out of Stoneridge (SRI) in Q3 2019, closing a stake of 19,730 shares — an estimated $622K sold.

Marshall Wace North America first reported a position in SRI in Q1 2017 and held it in 6 quarters. The position peaked at $2.48M in Q3 2017. 150 funds tracked by Wall St. Rank hold SRI as of Q3 2019.

  • Marshall Wace North America reported no remaining Stoneridge position as of Q3 2019 after selling out during the quarter.
  • Marshall Wace North America sold 19,730 Stoneridge shares in Q3 2019, an estimated $622K.
  • Marshall Wace North America first reported a position in Stoneridge in Q1 2017 and held it in 6 quarters.
  • Marshall Wace North America's Stoneridge position peaked at $2.48M in Q3 2017.
  • 150 funds tracked by Wall St. Rank held Stoneridge as of Q3 2019.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.